Traws Pharma, Inc. — Director's Dealing 2013

Jul 25, 2013

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2013-07-24

Reporting Person: GROOPMAN JEROME (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to purchase)	$6.13	2022-02-01	Common Stock (375)		Direct
Stock Option (right to purchase)	$13.28	2022-12-20	Common Stock (375)		Direct
Stock Option (right to purchase)	$13.28	2023-02-02	Common Stock (3000)		Direct
Stock Option (right to purchase)	$13.28	2023-02-02	Common Stock (18754)		Direct
Stock Option (right to purchase)	$14.74	2023-04-26	Common Stock (375)		Direct
Stock Option (right to purchase)	$14.74	2023-05-15	Common Stock (375)		Direct

Footnotes

F1: This option, representing a right to purchase a total of 18,754 shares of Common Stock, is immediately exercisable and vests over 4 years from February 1, 2013, with 25% vesting on February 1, 2014 and 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date.